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Abstract
Background: Although Female Genital Mutilation/Cutting (FGM/C) is internationally considered a harmful practice,
it is increasingly being medicalized allegedly to reduce its negative health effects, and is thus suggested as a harm
reduction strategy in response to these perceived health risks. In many countries where FGM/C is traditionally
practiced, the prevalence rates of medicalization are increasing, and in countries of migration, such as the United
Kingdom, the United States of America or Sweden, court cases or the repeated issuing of statements in favor of
presumed minimal forms of FGM/C to replace more invasive forms, has raised the debate between the medical
harm reduction arguments and the human rights approach.
Main body: The purpose of this paper is to discuss the arguments associated with the medicalization of FGM/C, a
trend that could undermine the achievement of Sustainable Development Goal 5.3. The paper uses four country
case studies, Egypt, Indonesia, Kenya and UK, to discuss the reasons for engaging in medicalized forms of FGM/C,
or not, and explores the ongoing public discourse in those countries concerning harm reduction versus human
rights, and the contradiction between medical ethics, national criminal justice systems and international conventions.
The discussion is structured around four key hotly contested ethical dilemmas. Firstly, that the WHO definition of
medicalized FGM/C is too narrow allowing medicalized FGM to be justified by many healthcare professionals as a form
of harm reduction which contradicts the medical oath of do no harm. Secondly, that medicalized FGM/C is a human
rights abuse with lifelong consequences, no matter who performs it. Thirdly, that health care professionals who
perform medicalized FGM/C are sustaining cultural norms that they themselves support and are also gaining
financially. Fourthly, the contradiction between protecting traditional cultural rights in legal constitutions versus
human rights legislation, which criminalizes FGM/C.
Conclusion: More research needs to be done in order to understand the complexities that are facilitating the
medicalization of FGM/C as well as how policy strategies can be strengthened to have a greater de-medicalization
impact. Tackling medicalization of FGM/C will accelerate the achievement of the Sustainable Development Goal of
ending FGM by 2030.
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Plain English summary
Although Female Genital Mutilation/Cutting (FGM/C)
is internationally considered a harmful practice, it is
increasingly being medicalized allegedly to reduce its
negative health effects, and is thus suggested as a harm
reduction strategy in response to these perceived health
risks.
The purpose of this paper is to discuss the arguments
associated with the medicalization of FGM/C, a trend
that could undermine the Sustainable Development Goal
(5.3) to end FGM/C by 2030. The paper discusses the
reasons for engaging in medicalized forms of FGM/C, or
not, by exploring ongoing public discourses in four
country case studies: Egypt, Indonesia, Kenya and UK.
The discussion is structured around four key hotly con-
tested ethical dilemmas. Firstly, that the WHO definition
of medicalized FGM/C is too narrow allowing medical-
ized FGM to be justified by many healthcare profes-
sionals as a form of harm reduction which contradicts
the medical oath of do no harm. Secondly, that medical-
ized FGM/C is a human rights abuse with lifelong conse-
quences, no matter who performs it. Thirdly, that health
care professionals who perform medicalized FGM/C are
sustaining cultural norms that they themselves support
and are also gaining financially. Fourthly, the contradic-
tion between protecting traditional cultural rights in legal
constitutions versus human rights legislation, which crimi-
nalizes FGM/C.
The paper concludes that more research needs to be
done in order to understand the complexities that are
facilitating the medicalization of FGM/C as well as how
policy strategies can be strengthened to accelerate the
achievement of the Sustainable Development Goal of
ending FGM by 2030.
Background
The trend towards medicalization of FGM/C
The World Health Organization defines the “medicalization”
of FGM/C as situations in which FGM/C is practiced by any
category of health professionals, whether in a public or a pri-
vate clinic, at home or elsewhere, at any point in a female’s
life (including reinfibulation1) [2]. Health professionals in-
volved in medicalization include physicians, assistant physi-
cians, clinical officers, nurses, midwives, trained traditional
birth attendants (TBAs), gynecologists/ obstetricians, plastic
surgeons, and other personnel providing health care to the
population, in both private and public sectors. They may be
undergoing medical training, working in the medical sector
or be retired [2].
Medicalization of FGM/C continues to rise in many
countries despite increasing numbers of countries legis-
lating against the practice. Based on self-reported Demo-
graphic and Health Survey (DHS) data in 25 countries,
Shell-Duncan and colleagues estimated that 26% of the
women in the age cohort 15–49, which equals to nearly
16 million women, report having been cut by a medical
professional [3]. Medicalization rates, as the percent of
FGM/C performed by a medical professional, are highest
in the following five countries: Sudan (67%), Egypt
(38%), Guinea (15%), Kenya (15%) and Nigeria (13%),
and rates are rising in all of these countries, except
Nigeria [3]. The performance of the procedure by skilled
medical professionals in any setting is systematically
documented through the inclusion of a question on who
performs the cutting in the DHS module on FGM/C.
The increasing use of medical staff and equipment has
also been noted in Somaliland [4]. Reinfibulation is esti-
mated to affect 20 million women globally and between
10 and 16 million women are likely to experience medical-
ized reinfibulation. Reinfibulation, medicalized or not, is
documented in many countries where infibulation is
(highly) prevalent, e.g. in Sudan, Somalia, Djibouti and
Eritrea [5] as well as in Europe and North America [6, 7].
This paper will use evidence from four countries (Egypt,
Indonesia, Kenya and UK) to explore current debates
concerning the medicalization of FGM/C.
Policies on medicalization of FGM/C
Initially, campaigns against FGM/C stressed the adverse
health consequences of the practice, assuming that this
would help to raise awareness of the health risks and in
turn motivate people to abandon the practice [8]. How-
ever, it is speculated that the health approach taken in
these campaigns has unintentionally motivated the
medicalization of FGM/C, at both demand and supply
side [2]. In 2009 the World Health Organisation
(WHO), the United Nations Children’s Fund (UNICEF)
and the United Nations Populations Fund (UNFPA)
condemned the medicalization of FGM/C in any setting
[9], however, WHO had already raised this issue 30 years
earlier (1979) at an international conference, stating “it
is unacceptable to suggest that performing less invasive
forms of FGM/C within medical facilities will reduce
health complications” [1]. The most recent guidance by
WHO on the management of health complications from
FGM/C states: “stopping medicalization of FGM/C is an
essential component of a holistic, human-rights based
approach towards the elimination of the practice” [1].
In December 2012, the United Nations General As-
sembly adopted the first ever Resolution to ban FGM/C
worldwide.[10] Resolution A/RES/67/146 was co-
sponsored by two thirds of all UN members and was
adopted by consensus of all UN members. Its adoption
1Reinfibulation is the procedure to narrow the vaginal opening in a
woman after she has been deinfibulated (i.e. after childbirth); also
known as re-suturing [1]
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reflected the universal agreement that FGM/C consti-
tutes a violation of human rights, which all countries of
the world should address through ‘all necessary measures,
including enacting and enforcing legislations to prohibit
FGM/C and to protect women and girls.’ More recently, in
September 2015, the global community agreed a new set of
development goals, the United Nations Sustainable Devel-
opment Goals (SDGs), which includes Sustainable Develop-
ment Goal 5: achieve gender equality and empower all
women and girls [11, 12]. This Goal includes a target to
eliminate all harmful traditional practices, including FGM/
C (SDG 5.3), by 2030, a signal of international political will
to end the practice of FGM/C globally.
FGM/C whether traditionally performed or medical-
ized, is now recognized internationally as a violation of
girls’ and women’s rights and as an expression of gen-
dered violence, with a demonstrated impact on women’s
sexual and reproductive health. Governments worldwide
are thus obliged to take measures to prevent and elimin-
ate FGM/C, including medicalized forms of the practice,
and can be held accountable for failing to take steps to
prohibit the practice of FGM/C through legislative and
other measures. Some countries have increased the
prison sentences when health professionals have been
convicted of performing FGM/C, and some also provide
for the revocation of licenses of health professionals if
they perform FGM/C [13]. However, even if the legal
framework is put in place, a number of challenges re-
main. This paper contributes to four current hotly con-
tested debates on the medicalization of FGM/C, namely:
i. That the WHO definition of medicalized FGM/C is
too narrow allowing medicalized FGM to be
justified by many healthcare professionals as a form
of harm reduction which contradicts the medical
oath of do no harm.
ii. That medicalized FGM/C is a human rights abuse
with life long consequences, no matter who
performs it.
iii. That health care professionals who perform
medicalized FGM/C are sustaining cultural norms
that they themselves support and are also gaining
financially.
iv. The contradiction between protecting traditional
cultural rights in legal constitutions versus human
rights legislation, which criminalizes FGM/C.
Current debates on medicalization of FGM/C
When does FGM/C become defined as ‘medicalized FGM/
C’ and is medicalized FGM/C an acceptable form of ‘harm
reduction’?
Although not specifically addressed in the WHO defin-
ition, we argue that medicalization of FGM/C might also
include performing less invasive forms of FGM/C, often
promoted as ‘a harm reduction strategy’. This form of
medicalization has been documented in African coun-
tries where FGM/C is prevalent, as well as in European
countries and the USA. Indeed, in 2010 the American
Academy of Pediatrics issued a position statement in
which they suggested that ‘it might be more effective if
federal and state laws enabled pediatricians to reach out
to families by offering a ritual nick as a possible com-
promise to avoid greater harm”. Such a nick, or prick,
would consist of pricking the prepuce of the clitoris,
without removal of tissue. A study in Somaliland, for ex-
ample, showed that there is a trend towards milder
forms of FGM/C, with “pharaonic circumcision” (Type
III or infibulation) being replaced by “sunna” cutting
[14]. Moreover, the study showed that girls are more
likely to undergo the procedure in a medical facility
where staff has received at least some medical training.
A recent study from Nigeria demonstrated that the cam-
paign and legislation against FGM/C and the training of
nurses concerning the health implications of FGM/C
made them more cautious and because they knew the
complications, they were more likely to only nick the
clitoris enough to cause bleeding and thus satisfy parents
that the procedure had been done, without removing
much tissue [15].
Another complication with defining medicalized FGM/
C is whether the use of medical instruments (such as ster-
ile razor blades or surgical blades, forceps), antibiotics
and/or anesthetics to carry out FGM/C, especially when
used by traditional practitioners, should be considered as
a form of medicalized FGM/C. Data on this are notably
lacking, and only anecdotal evidence is available. In
Guinea, the use of razor blades instead of traditional in-
struments is attributed to the increasing medicalization of
the procedure and sensitization campaigns [16] A qualita-
tive study conducted in four communities in the Nigerian
States of Delta, Ekiti, Imo and Kaduna, showed that health
workers used a range of essential supplies when carrying
out FGM/C: antiseptic, artery forceps, surgical scissors or
blades, cotton wool, and antibiotics. They described the
steps of the procedure as: “using an antiseptic to clean the
area, clamping the tissue with forceps, cutting the tissue
with scissors or a surgical blade, applying pressure with
cotton wool to control bleeding, cleaning the area again
with an antiseptic, and applying an oil or Vaseline”. Some
‘health workers’ mentioned also administering pain relief
and prescribing antibiotics [15].
Finally, we want to highlight the issue of medicalized
reinfibulation, and how a recent court case in the UK
demonstrates the difficulties in defining what constitutes
medicalized FGM/C, especially in the context of re-
stitching following the birth of a child (reinfibulation).
The UK case study (see Table 1) is a demonstration of
an unsuccessful legal case brought against a doctor who
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allegedly performed a reinfibulation and illustrates the
difficulty of proving to a court that FGM/C has taken
place. However, the huge publicity that occurred during
and following the court case made it very clear that
medicalized, as well as traditional FGM/C, was against
the law and prosecutions would be brought. Since this
case in 2015, two further unsuccessful cases have been
brought in the UK against two different fathers of girls
who have allegedly been subjected to FGM/C. Again,
these showed a weakness in the law concerning the testi-
mony of the victims and expert evidence from health
professionals who could not agree whether FGM/C had
taken place on the girls. However, in February 2019 the
first successful case was prosecuted in the UK of a
mother who performed FGM/C using traditional tech-
niques, FGM/C on her three-year-old daughter.
Medicalized FGM/C: harm reduction or human rights
abuse?
One of the most important reasons given by health care
professionals who perform FGM/C is their belief that
when it is done by skilled professionals, it reduces the
immediate health risks and pain, especially when anti-
septic techniques, anesthetic and analgesic medication
are used [9]. Health professionals doing FGM/C might
indeed be able to control the immediate physical conse-
quences of cutting the genitals, such as the severe pain,
bleeding and infections. However, many health profes-
sionals who perform FGM/C have limited knowledge of
long-term health consequences of the procedure, in par-
ticular the mental health implications. Even if women do
not report physical after-effects of FGM/C, research sug-
gests that the majority of women subjected to FGM/C
have reported mental health problems and emotional
disorders with living with the effects of FGM/C [22]. A
study by Knipscheer indicated a high level of reporting
of severe depression, anxiety and Post Traumatic Stress
Disorder (PTSD) by FGM/C survivors [23]. Eisold found
that FGM/C can affect the emotional well-being of
women throughout their lives [24].
Whilst medicalized FGM/C might minimize – but not
avoid - some of the long-term physical consequences of
FGM/C, the fact remains that there are no perceived
health benefits of the practice itself. It is therefore con-
sidered to be against good medical practice and a viola-
tion of the medical code of ethics, as even “do less
harm” is contradictory to the Oath of Hippocrates ‘do
no harm’.
Still, the harm reduction approach dominates the dis-
course, as is demonstrated by the high numbers and in-
creasing rates of health professionals that engage in
performing FGM/C. Health professionals performing
FGM/C in order to provide a safer setting for the pro-
cedure are ignoring the human rights issues associated
with FGM/C, including the right to freedom from vio-
lence and discrimination, amongst others. The trend to
medicalize FGM/C is worrying, given that its impact on
the global campaign and efforts to end FGM/C is still
not clear. How the promotion of medicalized ‘safe’ or
‘light’ versions of cutting girls’ and women’s genitals in-
fluences these efforts is difficult to assess, but it is com-
monly believed that promoting medicalized forms of
FGM/C communicates the message to practicing
Table 1 United Kingdom – when does a medical procedure
become FGM/C?
In the United Kingdom (UK), FGM/C has been illegal since 1985 when
the Prohibition of Female Circumcision Act became law. In 2003 the law
was amended under the FGM Act (2003) to include an extra-territorial
clause. In 2015 provisions were strengthened under the Serious Crime
Act, which extended the scope of extra-territorial offences, granted
victims of FGM lifelong anonymity; and introduced a new offence of
failing to protect a girl at risk of FGM (Crown Prosecution Service, nd).
The law states it is a criminal offence to excise, infibulate or otherwise
mutilate the whole or any part of a female’s labia majora, labia minora
or clitoris. However no offence is committed by a registered healthcare
professional who performs: a surgical operation on a female which is
necessary for her physical or mental health; or a surgical operation on a
female who is in any stage of labour, or has just given birth, for
purposes connected with the labour or birth. It is also an offence to aid,
abet, counsel or procure FGM [17].
After 30 years with no prosecutions under the FGM/C legislation, the
first prosecution was brought to court in January 2015. It was a high
profile case involving an alleged medicalized re-infibulation by a doctor
in a Maternity Unit of a National Health Service (NHS) hospital in
London. The alleged offence took place in November 2012 when a 24-
year-old woman was brought into the Maternity Unit in labour with her
first child. It was apparent to the midwife in attendance that she had
been subjected to type 3 FGM infibulation (which had been performed
on her at the age of 6 in her home country, Somalia) and that this had
not been picked up earlier in her pregnancy and was making the birth
difficult [18, 19]. The doctor was called in and he cut the woman to
facilitate the safe birth of her child [18]. Following the delivery of the
child, the doctor, allegedly encouraged by her husband [18], sutured the
woman, to stop excessive bleeding. However it was claimed by the
prosecution that the suturing exceeded that which was medically
required and thus constituted re-infibulation [20]. The case thus revolved
around whether a figure of eight suture constituted re-infibulation [19].
In the period between when the alleged FGM took place and the court
case, the woman had delivered a second child with no need for surgical
intervention and she declined to give evidence in court [19, 21]. The
defendants (the doctor and the woman’s husband) were both acquitted
of the offence by the jury after only 25 min of deliberation [20, 21].
The case has thrown up a number of issues most notably how re-
infibulation is defined, i.e. when does a medical procedure become
FGM/C. In this prosecution the case consisted of debates and expert
witness evidence concerning one suture (in a figure of eight, part of
which involved the stitching of the labia). The prosecution claimed this
one stitch constituted FGM. This argument was supported by expert
evidence from health professionals including the midwife involved in
the delivery room at the time [18]. Other health professionals argued
otherwise, stating that as the woman had given birth to a second child
without having to be surgically cut then the suturing could not be
labeled as reinfibulation. The debate on when a medical procedure
crosses the legal line to become FGM has not been resolved. However,
whilst the prosecution did not result in a conviction, it did raise the
issue of the medicalization of FGM/C in the UK, whether this was
inadvertent or deliberate. It is not known if any or how many health
professionals are engaged in medicalized FGM/C in the UK, but this
highly publicized case provided a stark warning to the medical
profession that medicalized FGM will not be tolerated in the UK.
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communities that FGM/C is acceptable when done by
health professionals, and thus is a legitimation of the
practice [1]. This harm-reduction approach contrasts
with the human rights approach, which states that health
professionals performing FGM/C in order to provide a
safer setting for the procedure, are ignoring the human
rights aspects associated with FGM/C.
Furthermore, the assumption that medicalization re-
duces harm is not empirically proven. Moreover, in the
Indonesian case described in Table 2 there is anecdotal
evidence to the contrary, namely that midwives perform
more severe forms of FGM/C than traditional practi-
tioners. The case of Indonesia also shows that the
government has been oscillating between the human
rights approach and the harm reduction strategy. Govern-
ment policy has played a crucial key role in medicalizing
FGM/C in Indonesia, together with strong religious/social
norms that underpinned this medicalization.
Medicalized FGM/C: reflecting the social norm or used to
justify financial gain?
One aspect that plays a key role in health care profes-
sionals deciding to do FGM/C is that they commonly
share the same social norms regarding cutting the geni-
tals of girls and women, hence resisting the pressure or
the demand to do FGM/C from the community is chal-
lenging. A study from Nigeria for example, demon-
strated that most health workers that engage in FGM/C
do so because they share the same FGM/C beliefs as the
community they serve, and this was evidenced by the
fact that four out of five health workers with daughters
had also cut their own daughters [15]. Another study,
from Sudan, concluded that medicalization is primarily
driven by the demand motivated by social norms [31].
The patriarchal nature of FGM/C underpins many of
the arguments to continue FGM/C, whether it is medi-
calized or not, and parallels between FGM/C, patriarchy
and female genital surgeries have been discussed else-
where by various scholars (see for example Pedwell C
[32], Ogbe E et al. [33]).
However, the financial gains to perform FGM/C for
both health professionals and parents should not be
underestimated, as FGM/C can bring in additional income
to health professionals and for parents it can mean a
higher bride price/dowry can be expected when their
daughter is married. Health professionals’ motivation to
perform FGM/C is reinforced by the fact that many health
systems in countries where FGM/C is prevalent are weak,
and so extra financial income is attractive. Serour suggests
that medicalization of FGM/C is a major source of income
for those who perform it. Fees are high, especially in coun-
tries where FGM/C is illegal [9, 34].
This is demonstrated by the case study that looks at
Egypt, where medical doctors have taken the lead in the
Table 2 Indonesia – is the debate “harm-reduction vs. human
rights” meaningful?
Indonesia has one of the highest burdens of FGM/C in the world, with
51% of the girls 0 to 11 years having been circumcised [25]. In
Indonesia, it is widely believed that FGM/C is a necessary fulfilment of
the Islamic religion [26, 27]. The fatwa, a recognised body for the
preservation of Muslim culture in a secular-led government, argues in
favour of FGM/C, by defining FGM/C as the removal of the membrane
that covers the clitoris, through scratching without cutting or incision of
the clitoris.
FGM/C in Indonesia was traditionally conducted by traditional birth
attendants, as well as traditional and religious practitioners. When the
government rolled out a maternal health programme to reduce
maternal deaths in the 1990s, it transferred duties of maternity care and
delivery to midwives. Since then clinics and hospitals have increasingly
offered FGM/C as part of the delivery package with midwives being the
frequently cited personnel performing FGM/C [28]. The proportion of
FGM/C performed by midwives and other medical professionals has
sharply increased from 32 to 52% between 2003 and 2013 [25, 29].
Countrywide, two-thirds (65%) and two-fifths (40%) of the FGM/C in
urban and rural areas respectively, are now being performed by mid-
wives and other health personnel [25].
The last decade has seen the heightening of the debate on FGM/C in
Indonesia leading to periods of banning and unbanning of FGM/C.
Activists call for its banning while the fatwa religious fathers lobby for
its continuation. In the 1990s and early 2000s the government was silent
on the WHO’s global call to eliminate FGM/C [30]. In the absence of
government policy and intervention, midwives responded to women’s
demands for FGM/C by conducting FGM/C in health facilities to those
who requested it [28]. Following the call for the respect for women and
girls’ rights surrounding FGM/C, the government banned FGM/C in
2006. In response, the fatwa lobbied the government to rescind the ban
arguing that FGM/C was a cultural rite of passage for all Islamic women
and must be provided upon parental request on behalf of their children,
but that it must be done without causing psychological or physical
danger to the woman or girl. Instead of maintaining its stance on the
ban, the government gave in and spelt out conditions under which
FGM/C could be done. A standard operating procedure allowing only
medical personnel to conduct FGM/C in a safe and hygienic manner
and to children of parents who requested it was then put in place.
In 2014 women’s organizations successfully contested the policy
arguing that FGM/C has no medical benefits for women and girls as
opposed to male circumcision. Despite the ban that prohibits FGM/C
being in place, no sanctions are given for those who transgress this law.
Women’s organizations recommended that the government should
address the problem, including providing rehabilitation to women living
with FGM/C, criminalise the practice and campaign against the practice
[25].
Medicalized FGM/C is argued to be a better of the two evils
(medicalized versus traditional FGM/C) in that it is done by trained and
skilled health professionals in hygienic and medically controlled
situations compared to the traditional birth attendants who conduct it
in uncontrolled settings with severe pain and complications [26].
However, the opposite has been reported as midwives in Indonesia,
were found to perform more invasive and painful forms of excision in
68–88% observed cases compared to 43–67% cases by traditional
providers [29]. There is also some concern that as FGM/C has become
more medicalised, more physically invasive forms of FGM/C are now
more common. However, there is also some evidence that midwives
who disagree with FGM/C are performing type 1 or type 4, to satisfy
parents that FGM/C has taken place but at the same time minimizing
the risk to girls, thus demonstrating that the human rights arguments
might gain some impact on the medicalization of FGM/C in Indonesia.
In a few instances midwives are said to provide “psychological FGM/C”
and not real FGM/C. Hidayana et al. argue that since parents do not
know how the midwives conduct FGM/C, some midwives who do not
support it pretend to be doing FGM/C to fulfil the client’s request [28].
This case also demonstrates that medical professionals are impacted on
by the same social norms as parents and stresses the role medical
professionals play in ending FGM/C, which is further discussed in the
following section.
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medicalization of FGM/C, often arguing that as FGM/C
is a strong social norm and will happen whatever, that it
is better that it is performed by a medical doctor than a
traditional practitioner (Table 3). It has also been argued
that many of these doctors support the practice for cul-
tural and religious reasons and in addition make a good
livelihood from performing the procedure. Despite cases
where girls have died following medicalized FGM/C, few
successful prosecutions have taken place against a med-
ical professional in Egypt [42]; a country where medical-
ized FGM/C is highly prevalent and numbers rising. The
Egyptian case study shows us the importance of the con-
text in which FGM/C arises.
FGM/C: cultural rights versus human rights?
Both the Egyptian case discussed above and the Kenyan
case discussed hereafter (Table 4) demonstrate how
the law has limited influence in contradiction with cul-
ture and tradition. It shows how FGM/C is embedded in
cultural and traditional norms and rights that are con-
sidered by proponents to prevail over the law of the
country.
As alluded to in the Kenyan case of a medical doctor
supporting the medicalization of FGM/C, there may be
gaps in the law that proponents of FGM/C might use to
push their agenda. This case indicates that some medical
practitioners themselves do not only medicalize, or
support it, but do so by exploiting gaps in the judicial
system hence derailing progress made towards aban-
donment of FGM/C.
Discussion
Tackling the medicalization of FGM/C needs to consider
the contested issues surrounding the debate of medical-
ized FGM/C. In the current paper we discussed four im-
portant issues and dilemmas that should be taken into
account: the trouble with defining FGM/C, the need to
contextualize FGM/C, the debate of harm-reduction ver-
sus social norm and the difficulty of applying a law when
Table 3 Egypt – the contradiction between social norms and
legal frameworks
Worldwide more than half of all medicalized FGM/C procedures are
performed in Egypt [3] and medicalization rates in Egypt are rising.
Available data show that the percentage of girls cut by health
professionals increased from 55% in 1995 to 77% in 2008 [35] and 84%
in 2014 (EDHS, 2014).
In Egypt, policies and laws related to the medicalization of FGM/C have
undergone a number of shifts. In 1994, in an attempt to improve the
safety of FGM/C, the government gave its consent for FGM/C when
performed by health personnel in public hospitals [35]. This government
consent aimed at improving the safety of FGM/C, in a context where
people viewed the practice as inevitable. The Egyptian Minister of
Health at the time stated that the medicalization of FGM/C would
reduce complications and eventually end the practice [9, 36]. Women’s
rights and health advocates criticized the consent as government
endorsement of FGM/C. In 1995, after the death of a girl in a hospital
during a FGM/C procedure [38], this policy was revised. First
governmental hospitals, and later private hospitals were banned from
performing the procedure, except ‘when medically necessary’. The
prerequisite of medical necessity functioned as a loophole until 2006
[35, 36, 38]. In 2007 further restrictions banned all state-licensed health
workers in either government or private clinics from performing FGM/C.
In 2008 performing FGM/C was criminalized in the penal code [35].
Initially FGM/C was covered as a misdemeanor, imposing the penalty of
imprisonment between 3 months and 2 years on practitioners of FGM/
C. In 2016, following several deaths of girls while undergoing FGM/C,
the law was strengthened and enforced with increased sentences. In
2016 the penalty of imprisonment was raised from five to 7 years for
medical practitioners. If the practice led to death or permanent disability
the imprisonment could be up to 15 years. Moreover, a penalty of
imprisonment between one and 3 years was imposed for any individual
who escorted the victims of such crimes to the perpetrators [39].
However, a number of recent studies reveal that despite these
policies and legal restrictions the medicalization of FGM/C continues
in Egypt [35, 40, 41].
Table 4 Kenya – the intersectionality between tradition, culture
and human rights
Kenya witnessed a gradual decline in prevalence of FGM/C from 38% in
1998 to 21% in 2014 (KDHS 2014). However, over the same time the
rates of medicalization have been on the rise, increasing from 34% in
1998 to 41% in 2008–09, followed by a subsequent drop in 2014 [3].
More worrying are the rates of medicalization of FGM/C of girls as
facilitated by their parents in Kenya which is reported to be 20% [40].
Kenya has taken steps towards criminalizing FGM/C, which is evidenced
by the various policies and laws passed in the recent past such as the
Prohibition of Female Genital Mutilation Act 2011 and the Child Act
policy. However, there are a number of challenges that Kenya has faced
with regard to the implementation of these laws and policies. For
example, on 13th June 2014, after some perpetrators of FGM/C were
arrested [43], more than 500 agitated women from the Maasai
community held a protest at a shopping center in Kajiado Central,
advocating for FGM/C and calling for the government to allow them to
practice FGM/C. The women demonstrated against the enforcement of
the law in their county after the arrest of the parents of a 13 year-old
girl who died in a botched traditional FGM/C procedure. The protesters
cited the Kenyan Constitution, which provides for the protection of
cultural and traditional rights and subsequently their right to practice
FGM/C viewed as an age-old custom that is believed to be necessary
for womanhood. Such cases begin to raise concerns about the need to
sensitize and create awareness among members of communities that
practice FGM/C about harmful practices and how they infringe on girls
and women’s rights to bodily and mental integrity. Communities need
to de- and re-construct social norms in order to make progress in
achieving the SDGs.
One of the latest challenges that has captured both local and
international attention is the recent court case, filed by a Kenyan, female
medical doctor petitioning the High Court to overturn the law that
outlaws FGM/C in Kenya. The medical doctor argued against the term
‘mutilation’ which she viewed as a ‘misnomer’, and reiterated “female
circumcision was part and parcel of African cultural practices before
colonialism, and as such should not be made illegal”. She added, “[ …]
once you reach adulthood there is no reason why you should not make
that decision”. She argued that “legalizing female circumcision will make
it easy for those who want to undergo it to seek the best medical
services, thus making the procedure safe” [44]. In her discussion, she
also justified the medicalization of the practice by saying that “female
circumcision [ …] can be made safe arguing that it is a minor surgical
procedure that does not require anesthesia or being put into a theater”
[44]. It demonstrates that FGM/C is a practice based on cultural beliefs
and deeply embedded social norms; even well educated health care
providers find it hard to not comply with the prevailing social norms.
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it contradicts cultural values and social norms. In con-
clusion to this paper we want to translate the discussions
above to some suggestions for the way forward.
Policy emphasizing the human rights approach
As demonstrated there is a tension between a pragmatic
harm reduction approach maintained by some health pro-
fessionals and the human rights approach that seeks to
safeguard girls and women’s bodily integrity. Social and
religious norms supporting the practice of FGM/C pose
serious challenges to the implementation of legislation
that aims to protect the human rights of women and girls.
In both Egypt and Indonesia the governments have at vari-
ous times supported the medicalization of FGM/C as a harm
reduction strategy, often under great pressure from religious
leaders, resulting in a confused response to FGM/C and its
medicalization which undermined efforts to end the prac-
tice in line with international agreements. In Kenya, Egypt
and Indonesia, FGM/C practicing communities and the
health profession have been very vocal and at times mili-
tant in advocating against national legislation banning
FGM/C. Very often these groups have used constitutional
arguments such as the preservation of cultural and trad-
itional rights, to support their case. These three case stud-
ies reveal that at various times over the last 20 years the
harm reduction approach to FGM/C has taken policy pre-
cedence over the human rights approach to FGM/C.
FGM/C is a strong social norm that makes it difficult
for individuals to challenge, as the practice often occurs
in societies where norms of collectivity are predominant.
The impact of these different settings on social norm
change and human rights is not in the scope of this
paper and has been discussed elsewhere by various au-
thors (see for example Diabate et al. [45], UNICEF [46],
Leye et al. [47]).
There is now a growing momentum in many high
FGM/C prevalence countries and others, to tackle FGM/
C from a human rights perspective, 25 years after the
World Conference on Human Rights held in Vienna,
Austria in 1993 accepted that FGM/C was a violation of
human rights. In 2008 the United Nations Special
Report on Torture stated that violence against women,
including FGM/C can be considered a violation of the
Convention Against Torture.[51] Regionally several
treaties and consensus documents call for the protection
of the rights of women and girls through the abandon-
ment of FGM/C. These include the African Charter on
Human and People’s Rights (The Banjul Charter) and the
Protocol on the Rights of Women in Africa (Maputo
Protocol), the African Charter on the Rights and Wel-
fare of the Child, and the European Convention for the
Protection of Human Rights and Fundamental Free-
doms [30]. More recently, in September 2017 at a
meeting in Egypt jointly organized by UNFPA and the
League of Arab States, public statements were made by
National Doctors’ Syndicates and Medical Councils as
well as the National Midwives Associations in the Arab
Region to end the medicalization of FGM/C.
Educating health professionals on FGM/C and its
consequences
Awareness raising on the sexual and reproductive health
consequences of FGM/C and the human rights viola-
tions, as well as building capacities through inclusion of
FGM/C in curricula or postgraduate training of profes-
sionals likely to deal with FGM/C are some of the most
commonly used strategies to involve health professionals
in countering medicalization. From the case studies dis-
cussed above the importance of having a clear definition
of medicalized FGM/C, such that it’s clear to health pro-
fessionals when they are performing FGM/C, and thus
breaking the law, is highlighted. Moreover, they should
be aware of the negative psychological and physical con-
sequences of performing FGM/C.
Training of health care professionals on FGM/C can
vary across and between countries and can take different
forms, such as the provision of specific training work-
shops on medicalization or general training on FGM/C,
the inclusion of FGM/C in medical curricula, or the
development of e-learning modules or other tools on
FGM/C. It should be noted however, that very few of
these training and capacity building efforts, especially re-
garding medicalization, are evaluated, hence it remains
unclear what the most effective methods of awareness
raising amongst health professionals might be. More-
over, a recent analysis of the evidence on knowledge, ex-
periences and attitudes of health professionals towards
FGM/C showed that there are six areas for improvement
for health care providers. These areas are: knowledge of
FGM/C and its consequences, adherence to FGM/C pro-
tocols and guidelines, socially constructed acceptance of
FGM/C, knowledge of legislation and legal status of
FGM/C, condoning, sanctioning or supporting FGM/C
and information and training to work with women and
girls living with FGM/C [48]. This list indicates that
much work still needs to be done.
It is commonly assumed that the reproductive and
sexual health consequences, the legal repercussions as
well as the human rights dimension should be part of
any FGM/C module in the curricula of health profes-
sionals. The WHO Guidelines (2016) on the manage-
ment of health complications from FGM/C, are useful
for designing pre- and in-service professional training
curricula for health care providers, and include the
above-mentioned aspects. However, too often, FGM/C is
not included in curricula on a systematic basis, and/or
medicalization and the preventive role of health profes-
sional is not addressed at all. Moreover, capacity-
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building on how to resist pressures from the community,
as well as communication techniques for social norm
change are rare. A study from Nigeria showed that
health workers should be educated and empowered to
advocate for the abandonment among patients but also
among fellow health workers [15]. Studies from The
Gambia showed that training programmes should be
modeled to fit the specific characteristics of the trainees
in terms of sex and ethnicity [49].
Detangling professional norms from social norms
The above demonstrates that any effort to deal with
medicalized FGM/C should take into account the con-
text in which it occurs. Health care providers’ under-
standing about FGM/C and how their opinions are
shaped by social norms should be unpacked. Many
health professionals are not aware of the long-term
health implications of FGM/C and the fact that it is a
violation of human rights and a breach of medical ethics,
despite many regional and global protocols cited above
condemning it. Moreover, health professionals often
share the social norms of FGM/C being an important
cultural tradition. Additionally, the financial reward for
performing FGM/C is attractive to health professionals,
especially in a weak health system.
We are therefore advocating that health professionals
receive training to raise their knowledge of the issues
surrounding FGM/C and the awareness that performing
FGM/C is in contradiction with the Oath of Hippocrates
‘you should do not harm’. In particular, medicalization
of FGM/C and how to tackle it should be part of any
curriculum of health professionals (pre and postgraduate
training). The legal interpretations of what constitutes a
crime with regards to medicalization of FGM/C need to
be made clear among health professionals.
Codes of conduct or position statements by profes-
sional organizations have been issued both in Western
countries as well as in countries where FGM/C is most
prevalent. Some of these position statements have
caused controversy, such as the 2010 Statement by the
American Association of Pediatrics that promoted the
performance of a ‘ritual nick’. This statement was revised
after outrage and fierce opposition by WHO and others.
The European Academy of Pediatricians on the other
hand, clearly states: “It also calls upon all physicians to
help to stop this practice. The practice of offering a “clit-
oral nick”, a minimal pinprick, must also be condemned
as an unnecessary and extremely painful procedure [50]”.
Motivate health care providers as agents of change for
ending FGM/C
Even though health professionals are at the core of the
medicalization issue, they can and are targeted as part of
the solution to reverse the medicalization of FGM/C.
Given that they are important role models in societies,
they are often key in becoming agents of change regard-
ing FGM/C. However, a scoping survey would need to
be conducted in each country where medicalized FGM/
C is performed to assess the knowledge, attitudes and
practices of health professionals in the practicing of
medicalized FGM/C.
From our discussion above, it is clear that more atten-
tion should go to how health care professionals can be
used as agents of change for ending FGM/C. This can
be done through:
– Including, more systematically, the human rights
framework and the ethics of medicalization of FGM/
C in curricula of health professionals’ education and
training.
– Building bridges between sectors: linkages between
health professionals and legal stakeholders should
be explored and reinforced in order to make the
implementation of laws banning FGM/C more
effective.
– Establishing collaborations between health
professionals and religious leaders to agree that
FGM/C is not a religious requirement and to
communicate this to FGM/C practicing
communities.
– Developing strategies on how health professionals
can deal with social pressures from the
community wanting to continue with FGM/C and
to challenge the social norms perpetuating the
practice.
– Urging Professional Medical Associations to
reinforce the unethical nature of the medicalization
of FGM/C and produce public statements and
protocols advocating for the ending of FGM/C
whether performed in traditional or medicalized
settings, including reinfibulation.
Conclusion
This paper has discussed the complex ethical debates
that accompany the medicalization of FGM/C, and the
contradictions between the social and cultural norms
supporting the continuation of FGM/C and the human
rights of women and girls. It is clear that more attention
should go to how health care professionals can be used
as agents of change for ending FGM/C. It is also clear
that more research needs to be done in order to de-
cipher the code that will facilitate the detangling of these
social norms from health professional norms and human
rights. It is essential that we have a deeper understand-
ing of the issue and the process of medicalization of
FGM/C if the United Nations SDG 5.3 of ending FGM
by 2030 is to be achieved.
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